These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18406008)

  • 21. Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues.
    Morimoto R; Satoh F; Murakami O; Totsune K; Arai Y; Suzuki T; Sasano H; Ito S; Takahashi K
    Peptides; 2008 May; 29(5):873-80. PubMed ID: 17686550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.
    Zomer E; de Ridder I; Kompa A; Komesaroff P; Gilbert R; Krum H
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1147-50. PubMed ID: 18505448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurobiology of REM and NREM sleep.
    McCarley RW
    Sleep Med; 2007 Jun; 8(4):302-30. PubMed ID: 17468046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A vasoactive peptide: urotensin II].
    Liu GQ; Zeng ZP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):525-8. PubMed ID: 16178453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.
    Dai HY; Guo XG; Ge ZM; Li ZH; Yu XJ; Tang MX; Zhang Y
    J Diabetes Complications; 2008; 22(2):137-43. PubMed ID: 18280445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urotensin II and cardiovascular diseases.
    Thanassoulis G; Huyhn T; Giaid A
    Peptides; 2004 Oct; 25(10):1789-94. PubMed ID: 15476947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor.
    Yoshimoto T; Matsushita M; Hirata Y
    Peptides; 2004 Oct; 25(10):1775-81. PubMed ID: 15476945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse.
    Wang HX; Zeng XJ; Liu Y; Wang J; Lu LQ; Hao G; Zhang LK; Tang CS
    Regul Pept; 2009 Apr; 154(1-3):85-90. PubMed ID: 19323985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative distribution of the mRNAs encoding urotensin I and urotensin II in zebrafish.
    Parmentier C; Hameury E; Lihrmann I; Taxi J; Hardin-Pouzet H; Vaudry H; Calas A; Tostivint H
    Peptides; 2008 May; 29(5):820-9. PubMed ID: 18403048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.
    Sugo T; Murakami Y; Shimomura Y; Harada M; Abe M; Ishibashi Y; Kitada C; Miyajima N; Suzuki N; Mori M; Fujino M
    Biochem Biophys Res Commun; 2003 Oct; 310(3):860-8. PubMed ID: 14550283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modulation by the hypocretinergic/orexinergic neurotransmission system in sleep-wakefulness cycle states].
    del Cid-Pellitero E; Garzón M
    Rev Neurol; 2007 Oct 16-31; 45(8):482-90. PubMed ID: 17948215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased circulating urotensin II in cirrhosis: potential implications in liver disease.
    Kemp W; Roberts S; Krum H
    Peptides; 2008 May; 29(5):868-72. PubMed ID: 17913301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.
    Zeng ZP; Liu GQ; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X; Liu C
    Ann N Y Acad Sci; 2006 Aug; 1073():284-9. PubMed ID: 17102097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urotensin II: lessons from comparative studies for general endocrinology.
    Lu W; Abdel-Razik AE; Ashton N; Balment RJ
    Gen Comp Endocrinol; 2008 May; 157(1):14-20. PubMed ID: 18440535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor.
    Grieco P; Rovero P; Novellino E
    Curr Med Chem; 2004 Apr; 11(8):969-79. PubMed ID: 15078159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationships of urotensin II and URP.
    Leprince J; Chatenet D; Dubessy C; Fournier A; Pfeiffer B; Scalbert E; Renard P; Pacaud P; Oulyadi H; Ségalas-Milazzo I; Guilhaudis L; Davoust D; Tonon MC; Vaudry H
    Peptides; 2008 May; 29(5):658-73. PubMed ID: 17931747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts.
    Prosser HC; Leprince J; Vaudry H; Richards AM; Forster ME; Pemberton CJ
    Peptides; 2006 Dec; 27(12):3261-8. PubMed ID: 17097764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5.
    Malagon MM; Molina M; Gahete MD; Duran-Prado M; Martinez-Fuentes AJ; Alcain FJ; Tonon MC; Leprince J; Vaudry H; Castaño JP; Vazquez-Martinez R
    Peptides; 2008 May; 29(5):711-20. PubMed ID: 18289730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortistatin--functions in the central nervous system.
    de Lecea L
    Mol Cell Endocrinol; 2008 May; 286(1-2):88-95. PubMed ID: 18374474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
    Mamelak M
    Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.